Saponin from Periploca forrestii Schltr Mitigates Oxazolone-Induced Atopic Dermatitis via Modulating Macrophage Activation

Atopic dermatitis (AD) is a relapsing, acute, and chronic skin disease featured by intractable itching, eczematous skin. Conventional therapies based on immunosuppression such as corticosteroids are associated with multiple adverse reactions. Periploca forrestii Schltr saponin (PFS) was shown to pot...

Full description

Saved in:
Bibliographic Details
Main Authors: Luting Zeng, Yingqin Liu, Congcong Xing, Yijie Huang, Xin Sun, Guangchen Sun
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2020/4346367
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849414455750819840
author Luting Zeng
Yingqin Liu
Congcong Xing
Yijie Huang
Xin Sun
Guangchen Sun
author_facet Luting Zeng
Yingqin Liu
Congcong Xing
Yijie Huang
Xin Sun
Guangchen Sun
author_sort Luting Zeng
collection DOAJ
description Atopic dermatitis (AD) is a relapsing, acute, and chronic skin disease featured by intractable itching, eczematous skin. Conventional therapies based on immunosuppression such as corticosteroids are associated with multiple adverse reactions. Periploca forrestii Schltr saponin (PFS) was shown to potently inhibit murine arthritis by protecting bone and cartilage injury and suppressing NF-κB activation. However, its therapeutic effect on oxazolone-induced atopic dermatitis (AD) and the underlying mechanisms on macrophage are still unclear. The AD-like dermatitis was induced by repeated oxazolone challenge to the skin of BALB/c mice in vivo. Blood and ears were biochemically or histologically processed. RT-PCR, western blotting, and ELISA were conducted to evaluate the expression of macrophage factors. Mouse bone marrow-derived macrophages (BMDMs) stimulated with lipopolysaccharide (LPS) were used as a model in vitro. PFS treatment inhibited AD-like dermatitis development. PFS downregulated epidermis thickness and cell infiltration, with histological analysis of the skin lesion. PFS alleviated plasma immunoglobulin (Ig) E, IgG2a, and IgG1 levels. PFS downregulated the expression of M1 macrophage factors, tumor necrosis factor- (TNF-) α, interleukin- (IL-) 6, monocyte chemotactic protein-1 (MCP-1), and nitric oxide synthase2 (NOS2), and M2 macrophage factors, IL-4, arginase1 (Arg1) and CD163 in AD-like skin, which were confirmed by western blot and ELISA analysis. In addition, PFS inhibited LPS-induced macrophage polarization via the inhibition of the phosphorylation of signal transducer and activator of transcription 3 (STAT3) and nuclear translocation of NF-κB p65. These results suggest that PFS exerted an antidermatitis effect against oxazolone by modulating macrophage activation. PFS administration might be useful in the treatment of AD and inflammatory skin diseases.
format Article
id doaj-art-68172b0636244e4894edda53382bb7d9
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-68172b0636244e4894edda53382bb7d92025-08-20T03:33:50ZengWileyMediators of Inflammation0962-93511466-18612020-01-01202010.1155/2020/43463674346367Saponin from Periploca forrestii Schltr Mitigates Oxazolone-Induced Atopic Dermatitis via Modulating Macrophage ActivationLuting Zeng0Yingqin Liu1Congcong Xing2Yijie Huang3Xin Sun4Guangchen Sun5Pharmacy College, Guilin Medical University, No. 109 North Second Huancheng Road, Qixing District, Guilin, 541004 Guangxi, ChinaBiotechnology College, Guilin Medical University, Guilin, Guangxi, ChinaPharmacy College, Guilin Medical University, No. 109 North Second Huancheng Road, Qixing District, Guilin, 541004 Guangxi, ChinaPharmacy College, Guilin Medical University, No. 109 North Second Huancheng Road, Qixing District, Guilin, 541004 Guangxi, ChinaMedical College, Xiamen University, Xiamen, Fujian, ChinaPharmacy College, Guilin Medical University, No. 109 North Second Huancheng Road, Qixing District, Guilin, 541004 Guangxi, ChinaAtopic dermatitis (AD) is a relapsing, acute, and chronic skin disease featured by intractable itching, eczematous skin. Conventional therapies based on immunosuppression such as corticosteroids are associated with multiple adverse reactions. Periploca forrestii Schltr saponin (PFS) was shown to potently inhibit murine arthritis by protecting bone and cartilage injury and suppressing NF-κB activation. However, its therapeutic effect on oxazolone-induced atopic dermatitis (AD) and the underlying mechanisms on macrophage are still unclear. The AD-like dermatitis was induced by repeated oxazolone challenge to the skin of BALB/c mice in vivo. Blood and ears were biochemically or histologically processed. RT-PCR, western blotting, and ELISA were conducted to evaluate the expression of macrophage factors. Mouse bone marrow-derived macrophages (BMDMs) stimulated with lipopolysaccharide (LPS) were used as a model in vitro. PFS treatment inhibited AD-like dermatitis development. PFS downregulated epidermis thickness and cell infiltration, with histological analysis of the skin lesion. PFS alleviated plasma immunoglobulin (Ig) E, IgG2a, and IgG1 levels. PFS downregulated the expression of M1 macrophage factors, tumor necrosis factor- (TNF-) α, interleukin- (IL-) 6, monocyte chemotactic protein-1 (MCP-1), and nitric oxide synthase2 (NOS2), and M2 macrophage factors, IL-4, arginase1 (Arg1) and CD163 in AD-like skin, which were confirmed by western blot and ELISA analysis. In addition, PFS inhibited LPS-induced macrophage polarization via the inhibition of the phosphorylation of signal transducer and activator of transcription 3 (STAT3) and nuclear translocation of NF-κB p65. These results suggest that PFS exerted an antidermatitis effect against oxazolone by modulating macrophage activation. PFS administration might be useful in the treatment of AD and inflammatory skin diseases.http://dx.doi.org/10.1155/2020/4346367
spellingShingle Luting Zeng
Yingqin Liu
Congcong Xing
Yijie Huang
Xin Sun
Guangchen Sun
Saponin from Periploca forrestii Schltr Mitigates Oxazolone-Induced Atopic Dermatitis via Modulating Macrophage Activation
Mediators of Inflammation
title Saponin from Periploca forrestii Schltr Mitigates Oxazolone-Induced Atopic Dermatitis via Modulating Macrophage Activation
title_full Saponin from Periploca forrestii Schltr Mitigates Oxazolone-Induced Atopic Dermatitis via Modulating Macrophage Activation
title_fullStr Saponin from Periploca forrestii Schltr Mitigates Oxazolone-Induced Atopic Dermatitis via Modulating Macrophage Activation
title_full_unstemmed Saponin from Periploca forrestii Schltr Mitigates Oxazolone-Induced Atopic Dermatitis via Modulating Macrophage Activation
title_short Saponin from Periploca forrestii Schltr Mitigates Oxazolone-Induced Atopic Dermatitis via Modulating Macrophage Activation
title_sort saponin from periploca forrestii schltr mitigates oxazolone induced atopic dermatitis via modulating macrophage activation
url http://dx.doi.org/10.1155/2020/4346367
work_keys_str_mv AT lutingzeng saponinfromperiplocaforrestiischltrmitigatesoxazoloneinducedatopicdermatitisviamodulatingmacrophageactivation
AT yingqinliu saponinfromperiplocaforrestiischltrmitigatesoxazoloneinducedatopicdermatitisviamodulatingmacrophageactivation
AT congcongxing saponinfromperiplocaforrestiischltrmitigatesoxazoloneinducedatopicdermatitisviamodulatingmacrophageactivation
AT yijiehuang saponinfromperiplocaforrestiischltrmitigatesoxazoloneinducedatopicdermatitisviamodulatingmacrophageactivation
AT xinsun saponinfromperiplocaforrestiischltrmitigatesoxazoloneinducedatopicdermatitisviamodulatingmacrophageactivation
AT guangchensun saponinfromperiplocaforrestiischltrmitigatesoxazoloneinducedatopicdermatitisviamodulatingmacrophageactivation